Blood Cancer Journal Blood cancer journal, 11(2):38. Nature Publishing Group Blood Cancer Journal, Vol 11, Iss 2, Pp 1-8 (2021) van der Horst, H J, de Jonge, A V, Hiemstra, I H, Gelderloos, A T, Berry, D R A I, Hijmering, N J, van Essen, H F, de Jong, D, Chamuleau, M E D, Zweegman, S, Breij, E C W, Roemer, M G M & Mutis, T 2021, ' Epcoritamab induces potent anti-tumor activity against malignant B-cells from patients with DLBCL, FL and MCL, irrespective of prior CD20 monoclonal antibody treatment ', Blood cancer journal, vol. 11, no. 2, 38 . https://doi.org/10.1038/s41408-021-00430-6
Van der Horst, H J, de Jonge, A V, Hiemstra, I H, Gelderloos, A T, Berry, D R, Hijmering, N J, de Jong, D, Chamuleau, M E D, Zweegman, S, Breij, E C W, Roemer, M G M & Mutis, T 2019, ' Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo, Irrespective of Prior Treatment with CD20 Monoclonal Antibodies ', Blood, vol. 134 . https://doi.org/10.1182/blood-2019-125765 Blood, 134. American Society of Hematology